Regulatory T cells (Tregs) are linked to a reduction in alloreactive immune responses, but few studies have investigated the impact of hydroxyurea (HU) therapy on Tregs in sickle cell disease (SCD).
Our case-controlled study presented here included two groups, the first comprising 60 pediatric SCD patients, 30 of whom did not receive any treatment and 30 who received HU, and the second group consisting of 30 healthy controls. Flow cytometry was used to evaluate the percentage of CD4+CD25+highFoxp3+ Tregs present and their phenotypes.
The percentage of CD4+CD25+high Tregs was significantly increased in untreated SCD patients in comparison to treated SCD patients and controls. Conversely, treated SCD children had a lower percentage of CD4+CD25+high Tregs than controls. In addition, a significant increase in the percentage of CD4+CD25+highFoxp3+ Tregs was found in untreated SCD patients, compared to in HU-treated patients and controls. The percentage of naive CD45RA+ Tregs was significantly decreased in untreated SCD patients when compared to other groups.
Among children with SCD, HU treatment exhibited significant qualitative and quantitative effects on Tregs by decreasing their frequency, and increasing the proportion of naive CD45RA+ Tregs and reducing levels of the most suppressive Tregs: HLA-DR+, CD39+, and CD69+.
Among children with, SCD, HU treatment exhibited significant qualitative and quantitative effects on Tregs.
HU treatment in SCD decreases the frequency of Tregs, as well as the levels of the most suppressive Tregs: HLA-DR+, CD39+, and CD69+. At the same time, HU increases the proportion of naive CD45RA+ Tregs.
Our study showed the impact of HU therapy on Tregs in children with SCD.
Subscribe to Journal
Get full journal access for 1 year
only $30.69 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Borhade, M. B., & Kondamudi, N. P. In StatPearls (StatPearls Publishing, 2020).
Emokpae, M. A. et al. Relationship between neutrophil-to-lymphocyte ratio and inflammatory markers in sickle cell anaemia patients with proteinuria. Med. Sci. 4, 11 (2016).
Chou, S. T. et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122, 1062–1071 (2013).
Zahran, A. M. et al. Circulating microparticles in children with sickle cell anemia in a tertiary center in upper Egypt. Clin. Appl Thromb. Hemost. 25, 1076029619828839 (2019).
Zahran, A. M. et al. Effect of hydroxyurea treatment on the inflammatory markers among children with sickle cell disease. Clin. Appl Thromb. Hemost. 26, 1076029619895111 (2020).
Yazdanbakhsh, K. Immunoregulatory networks in sickle cell alloimmunization. Hematol. Am. Soc. Hematol. Educ. Program 2016, 457–461 (2016).
Vignali, D. A. et al. How regulatory T cells work. Nat. Rev. Immunol. 8, 523 (2008).
Baecher-Allan, C. et al. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176, 4622–4631 (2006).
Vingert, B. et al. Partial dysfunction of Treg activation in sickle cell disease. Am. J. Hematol. 89, 261–266 (2014).
Youssry, I. et al. Enhancing effect of hydroxyurea on Hb F in sickle cell disease: ten-year egyptian experience. Hemoglobin 41, 267–273 (2017).
Charache, S. et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N. Engl. J. Med. 332, 1317–1322 (1995).
Rêgo, M. J. et al. Evaluation of CD4(+) CD25(+) FoxP3(+) T cell populations, IL-10 production, and their correlation with clinical and biochemical parameters in sickle cell anemia patients with leg ulcers. Cytokine 75, 310–315 (2015).
South Egypt Cancer Institute, Assiut, Egypt (No. 120-2017).
The authors declare no competing interests.
All caregivers of all participants have given their informed written consent.
All protocols and investigations of our study followed the regulations of the research ethics committee of Assiut University (No. 120-2017).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zahran, A.M., Saad, K., Elsayh, K.I. et al. Regulatory T-cell phenotypes in children with sickle cell disease. Pediatr Res (2021). https://doi.org/10.1038/s41390-021-01627-y